General Information of the Compound
Compound ID |
CP0521934
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[3-[(2R,5S,8S,14R)-5-[3-(carbamoylamino)propyl]-14-[(4-hydroxyphenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]acetamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C38H48N8O8
|
||||||||||||||||||
Molecular Weight |
744.85
|
||||||||||||||||||
Canonical SMILES |
CN1[C@H](CCCNC(C)=O)C(=O)N[C@@H](CCCNC(N)=O)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)NCC(=O)N[C@H](Cc2ccc(O)cc2)C1=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C38H48N8O8/c1-23(47)40-17-6-10-32-36(52)44-29(9-5-18-41-38(39)54)35(51)45-30(21-25-11-14-26-7-3-4-8-27(26)19-25)34(50)42-22-33(49)43-31(37(53)46(32)2)20-24-12-15-28(48)16-13-24/h3-4,7-8,11-16,19,29-32,48H,5-6,9-10,17-18,20-22H2,1-2H3,(H,40,47)(H,42,50)(H,43,49)(H,44,52)(H,45,51)(H3,39,41,54)/t29-,30-,31+,32+/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
PHCCFUCCVACRJJ-GASGPIRDSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound